FibroGen announces CFO retirement of Pat Cotroneo; Juan Graham appointed effective Sept 7, 2021

KYNTRA BIO, INC.

Pat Cotroneo retires after 21 years; will serve as Executive Advisor to CEO through March 2022.
Juan Graham becomes CFO Sept 7, 2021; previously Global CFO/VP Finance Supply Chain at Johnson & Johnson.
Graham receives $470k base salary, 50% target bonus, 196k stock options, 35k RSUs, and up to $300k signing bonus.
Relocation assistance up to $100k (grossed up) and eligibility for change-in-control severance agreement.
No family relationships or related-party transactions disclosed with Mr. Graham.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Juan Graham

Chief Financial Officer

KYNB · KYNTRA BIO, INC.

Effective: 2021-09-07
Filed: August 16, 2021, 7:59 PM ET

the appointment of Juan Graham as CFO, effective September 7, 2021.

Role change

Pat Cotroneo

Chief Financial Officer

KYNB · KYNTRA BIO, INC.

Effective: 2021-09-06
Successor: Juan Graham
Filed: August 16, 2021, 7:59 PM ET

retirement of Pat Cotroneo as Chief Financial Officer ("CFO")

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Juan Graham was appointed as Chief Financial Officer at KYNTRA BIO, INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

the appointment of Juan Graham as CFO, effective September 7, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Pat Cotroneo retired as Chief Financial Officer at KYNTRA BIO, INC..

Action: retired
Role: Chief Financial Officer

Exact text from the filing

retirement of Pat Cotroneo as Chief Financial Officer ("CFO")

View on SEC.gov

KYNTRA BIO, INC. filing history →

Source: SEC EDGAR

accession 0001564590-21-044718

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.